SDMA (p-hydroxyazobenzene-p′-sulfonate) - CAS 1266235-58-8

SDMA p-Hydroxyazobenzene-p′-sulfonate is the p-hydroxyazobenzene-p′-sulfonate form of SDMA. It acts as an inhibitor of endogenous nitric oxide synthase (NO synthase) and serves as an activator of NF-κB, enhancing the expression of IL-6 and TNF-α. This compound remains stable in serum and plasma, making it a potential biomarker for liver and kidney dysfunction.

Endogenous Metabolite, NF-κB, NO Synthase

NF-κB, Metabolism, Immunology/Inflammation

1266169

C12H10N2O4S 1/2C8H18N4O2

379.4

OC(C=C1)=CC=C1N=NC2=CC=C(C=C2)S(=O)(O)=O.OC([C@@H](N)CCC/N=C(NC)/NC)=O.OC(C=C3)=CC=C3N=NC4=CC=C(C=C4)S(=O)(O)=O

-20°C

Ice Packs

Inhibitors & Agonists